Urmila Kerslake

1 week ago | vascularspecialistonline.com | Urmila Kerslake

“The reason to avoid a heart and vascular paradigm is [that] there really is no paradigm. There’s no set standard for how these things should function. There’s certainly no evidence that they benefit patient care,” says Malachi Sheahan III, MD, newly elected Society for Vascular Surgery (SVS) secretary. He continues: “And really what they’re set up as is a trap.

1 week ago | vascularspecialistonline.com | Urmila Kerslake

“Go back home and get a vascular center or […] get a vascular department, or, you know, assess the compensation [survey] results and, at least start considering a union, if it’s something feasible.” That was the new Society for Vascular Surgery (SVS) President Keith Calligaro’s distillation of the burning issues and strategies to empower vascular surgeons at the 2025 Vascular Annual Meeting (VAM) in New Orleans (June 4–7). Are heart and vascular centers beneficial to vascular surgeons?

3 weeks ago | vascularspecialistonline.com | Urmila Kerslake

One of the singular highlights of VAM 2025—the presidential introduction and address—will take place this morning from 11 a.m.–12 p.m. on Morial CC’s First Floor (Great Hall A), with SVS President Matthew Eagleton, MD, centering his focus on the Society’s anchor in a community commitment to patients and a spirit of shared purpose. The SVS seeks to lead, unite and rebuild vascular surgery’s future, he will tell the VAM audience.

Mar 22, 2024 | renalinterventions.net | Urmila Kerslake

Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, that will show creating arteriovenous fistulas with a vascular external support system, VasQ, decreases the median time to achieve two-needle cannulation by reducing the need to perform maturation procedures.

Mar 15, 2024 | vascularspecialistonline.com | Urmila Kerslake

Alik Farber, MD, professor of surgery and radiology at Boston University, is set to present the results of a multicenter U.S. study at the 2024 Society for Clinical Vascular Surgery (SCVS) annual meeting (March 16–20) in Scottsdale, Arizona, that will show creating arteriovenous fistulas with a vascular external support system, VasQ, decreases the median time to achieve two-needle cannulation by reducing the need to perform maturation procedures.